Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,432 | -1,612 | -4,220 | N/A | 6,190 |
| Depreciation Amortization | 2,697 | 327 | 60 | N/A | 680 |
| Accounts receivable | -117 | 12 | N/A | N/A | N/A |
| Other Working Capital | 518 | 125 | -150 | N/A | -8,730 |
| Other Operating Activity | 8,903 | 142 | 30 | 0 | 380 |
| Operating Cash Flow | $-2,431 | $-1,006 | $-4,280 | $N/A | $-1,480 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -65 | N/A | -50 | N/A | 240 |
| Other Investing Activity | 0 | 0 | 3,140 | 0 | 0 |
| Investing Cash Flow | $-65 | $N/A | $3,090 | $N/A | $240 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,000 | 976 | N/A | N/A | N/A |
| Debt Repayment | -26 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 7,000 | 0 | 950 | 0 | 0 |
| Financing Cash Flow | $8,974 | $976 | $950 | $N/A | $0 |
| Exchange Rate Effect | 45 | -113 | 0 | N/A | 0 |
| Beginning Cash Position | 862 | 862 | 1,090 | N/A | 5,210 |
| End Cash Position | 7,385 | 719 | 860 | N/A | 3,970 |
| Net Cash Flow | $6,523 | $-143 | $-230 | $N/A | $-1,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,431 | -1,006 | -4,280 | N/A | -1,480 |
| Capital Expenditure | -65 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -2,496 | -1,006 | -4,280 | 0 | -1,480 |